Your browser doesn't support javascript.
loading
TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.
McShan, Andrew C; Devlin, Christine A; Papadaki, Georgia F; Sun, Yi; Green, Adam I; Morozov, Giora I; Burslem, George M; Procko, Erik; Sgourakis, Nikolaos G.
Afiliação
  • McShan AC; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Devlin CA; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Papadaki GF; Department of Biochemistry and Cancer Center at Illinois, University of Illinois, Urbana, IL, USA.
  • Sun Y; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Green AI; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Morozov GI; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Burslem GM; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Procko E; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Sgourakis NG; Center for Computational and Genomic Medicine, Department of Pathology and Laboratory Medicine, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Nat Chem Biol ; 18(8): 859-868, 2022 08.
Article em En | MEDLINE | ID: mdl-35725941

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Antígenos de Histocompatibilidade Classe I Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulinas / Antígenos de Histocompatibilidade Classe I Idioma: En Ano de publicação: 2022 Tipo de documento: Article